B

Bicara Therapeutics Inc
NASDAQ:BCAX

Watchlist Manager
Bicara Therapeutics Inc
NASDAQ:BCAX
Watchlist
Price: 18.15 USD -1.14% Market Closed
Market Cap: 994.3m USD

Wall Street
Price Targets

BCAX Price Targets Summary
Bicara Therapeutics Inc

Wall Street analysts forecast BCAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCAX is 33.22 USD with a low forecast of 11.11 USD and a high forecast of 50.4 USD.

Lowest
Price Target
11.11 USD
39% Downside
Average
Price Target
33.22 USD
83% Upside
Highest
Price Target
50.4 USD
178% Upside
Bicara Therapeutics Inc Competitors:
Price Targets
IMDX
Insight Molecular Diagnostics Inc
40% Upside
MRUS
Merus NV
3% Upside
600201
Jinyu Bio-Technology Co Ltd
40% Downside
688105
Nanjing Vazyme Biotech Co Ltd
44% Upside
ATRA
Atara Biotherapeutics Inc
1% Downside
ARQT
Arcutis Biotherapeutics Inc
13% Upside
HRTX
Heron Therapeutics Inc
233% Upside
ARMP
Armata Pharmaceuticals Inc
60% Upside

Revenue
Forecast

Revenue Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCAX's stock price target?
Price Target
33.22 USD

According to Wall Street analysts, the average 1-year price target for BCAX is 33.22 USD with a low forecast of 11.11 USD and a high forecast of 50.4 USD.

Back to Top